{"contentid": 488538, "importid": NaN, "name": "Takeda launches production of blood cancer drug in Russia", "introduction": "Takeda Pharmaceutical has officially launched full-cycle production of its Ninlaro (ixazomib) \u00e2\u0080\u0093 a drug for the treatment of multiple myeloma - at its Russian plant in the Yaroslavl region, according to the company.", "content": "<p>Japan&rsquo;s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has officially launched full-cycle production of its Ninlaro (ixazomib) &ndash; a drug for the treatment of multiple myeloma - at its Russian plant in the Yaroslavl region, according to the company.&nbsp;</p>\n<p>Yaroslavl has become a second global site of the company where the production of finished dosage forms of ixazomib, a will take place and the first in Russia.&nbsp;</p>\n<p>So far, the Commission of the Ministry of Health of Russia has recommended the inclusion of ixazomib in the federal program of high-cost nosologies (VZN).&nbsp;</p>\n<p>According to Elena Kartasheva, president of Takeda Russia, total investments in the localization of production amounted to 590 million roubles ($7 million). It is planned, the drug will be supplied to the Russian market and the markets of countries of the Eurasian Economic Space.&nbsp;</p>", "date": "2021-05-05 10:15:00", "meta_title": "Takeda launches production of blood cancer drug in Russia", "meta_keywords": "Takeda, Ninlaro, Production, Multiple myeloma, Russia", "meta_description": "Takeda launches production of blood cancer drug in Russia", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-05 08:58:07", "updated": "2021-05-05 10:15:54", "access": NaN, "url": "https://www.thepharmaletter.com/article/takeda-launches-production-of-blood-cancer-drug-in-russia", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "takeda_hq_japan_large.jpg", "image2id": "takeda_hq_japan_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Hematology, Oncology", "topic_tag": "Focus On, Production, Russian market", "geography_tag": "Japan, Russia", "company_tag": "Takeda", "drug_tag": "Ninlaro", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-05 10:15:00"}